Abstract
Drug combination has been an important therapeutic development approach for cancer, viral or microbial infections, and other diseases involving complex biological networks. Synergistic drug combinations, which are more effective than predicted from summing effects of individual drugs, often achieve improved therapeutic index. Because drug-effect is dose-dependent, multiple doses of an individual drug need to be evaluated, giving rapidly escalating number of combinations and a challenging high dimensional statistical modeling problem. The lack of proper design and analysis methods for multi-drug combination studies have resulted in many missed therapeutic opportunities. It is known that, in the presence of model uncertainties, uniform measures that scatter the design points (the dose levels) uniformly in the experiment domain is the best strategy to yield maximum information on the dose response relation. This chapter will review some efficient experimental designs for drug combination studies especially those related to uniform measures and extensions using maximum entropy design.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdelbasit, K.M., Plackett, R.L.: Experimental design for joint action. Biometrics 38, 171–179 (1982)
Berenbaum, M.C.: What is synergy? Pharmacol. Rev. 41, 93–141 (1989)
Berenbaum, M.C., Yu, V.L., Felegie, T.P.: Synergy with double and triple antibiotic combinations compared. J. Antimicrob. Chemother. 12, 555–563 (1983)
Calzolari, D., et al.: Search algorithms as a framework for the optimization of drug combinations. PLoS Comput. Biol. 4(12), e1000249 (2008)
Casey, M., Gennings, C., Carter Jr., W.H., et al.: \(D_s\)-Optimal designs for studying combinations of chemicals using multiple fixed-ratio ray experiments. Environmetrics 16, 129–147 (2005)
Chen, H.X., Dancey, J.E.: Combinations of moleculartargeted therapies: opportunities and challenges. In: Kaufman, H.L., Wadler, S., Antman, K. (eds.) Molecular targeting in oncology, pp. 693–705. Humana Press, New Jersey (2008)
Carter Jr., W.H., Gennings, C., Staniswalis, J.G., et al.: A statistical approach to the construction and analysis of isobolograms. J. Am. Coll. Toxicol. 7, 963–973 (1988)
Cox, D.R., Reid, N.: The Theory of the Design of Experiments. Chapman and Hall/CRC, London (2000)
Cressie, N.A.C.: Statistics for Spatial Data. Wiley, New York (1993)
Fang, H.B., Chen, X., Pei, X. Y. et al.: Experimental design and statistical analysis for three-drug combination studies. Stat. Methods Med. Res. 26, 1261–1280 (2017)
Fang, H.B., Huang, H., Clarke, R., Tan, M.: Predicting multi-drug inhibition interactions based on signaling networks and single drug dose-response information. J. Comput. Syst. Biol. 2, 1–9 (2016)
Fang, H.B., Ross, D.D., Sausville, E., Tan, M.: Experimental design and interaction analysis of combination studies of drugs with log-linear dose responses. Stat. Med. 27, 3071–3083 (2008)
Fang, H.B., Tian, G.L., Li, W., et al.: Design and sample size for evaluating combinations of drugs of linear and loglinear dose response curves. J. Biopharm. Stat. 19, 625–640 (2009)
Fang, K.T.: Uniform Design and Uniform Design Tables. Science Press, Beijing (1994)
Fang, K.T., Li, R., Sudjianto, A.: Design and Modeling for Computer Experiments. Chapman and Hall/CRC, New York (2006)
Fang, K.T., Lin, D.K.J., Winker, P., Zhang, Y.: Uniform design: theory and application. Technometrics 42, 237–248 (2000)
Finney, D.J.: Probit Analysis, 3rd edn. Cambridge University Press, London (1971)
Fitzgerald, J.B., Schoeberl, B., Nielsen, U.B., et al.: Systems biology and combination therapy in the quest for clinical efficacy. Nat. Chem. Biol. 2, 458–466 (2006)
Gennings, C., Carter Jr., W.H., Carney, E.W., et al.: A novel flexible approach for evaluating fixed ratio mixtures of full and partial agonists. Toxicol. Sci. 80, 134–150 (2004)
Greco, W.R., Bravo, G., Parsons, J.C.: The search for synergy: a critical review from a response surface perspective. Pharmacol. Rev. 47, 331–385 (1995)
Hait, W.N.: Targeted cancer therapeutics. Cancer Res. 69, 1263–1267 (2009)
Hickernell, F.J.: A generalized discrepancy and quadrature error bound. Math. Comput. 67, 299–322 (1998)
Hopkins, A.L.: Network pharmacology: the next paradigm in drug discovery. Nat. Chem. Biol. 4, 682–690 (2008)
Huang, H., Fang, H.B., Tan, M.T.: Experimental design for multi-drug combination studies using signaling networks. Biometrics 74, 538–547 (2018)
Laska, E.M., Meisner, M., Siegel, C.: Simple designs and model-free tests for synergy. Biometrics 50, 834–841 (1994)
Lindley, D.V.: On a measure of information provided by an experiment. Ann. Math. Stat. 27, 986–1005 (1956)
Loewe, S.: Isobols of dose-effect relations in the combination of pentylenetetrazole and phenobarbital. J. Pharmacol. Exp. Ther. 114, 185–191 (1955)
Meadows, S.L., Gennings, C., Carter Jr., W.H., Bae, D.S.: Experimental design for mixtures of chemicals along fixed ratio rays. Environ. Health Perspect. 110, 979–983 (2002)
Santner, T.J., Williams, B.J., Notz, W.I.: The Design and Analysis of Computer Experiments. Springer, New York (2003)
Shiozawa, K., Nakanishi, T., Tan, M., et al.: Preclinical studies of vorinostat (suberoylanilide hydroxamic acid, saha) combined with cytosine arabinoside (ara-c) and etoposide for treatment of acute leukemias. Clin. Cancer Res. 15, 1698–1707 (2009)
Sobol’, I.M.: Global sensitivity indices for nonlinear mathematical models and their Monte Carlo estimates. Math. Comput. Simul. 55, 271–280 (2001)
Sobol’, I.M.: Theorems and examples on high dimensional model representation. Reliab. Eng. Syst. Safety 79, 187–193 (2003)
Straetemans, R., O’Brien, T., Wouters, L. et al.: Design and analysis of drug combination experiments. Biom. J. 47, 299–308 (2005)
Syracuse, K.C., Greco, W.R.: Comparison between the method of Chou and Talalay and a new method for the assessment of the combined effects of drugs: a Monte-Carlo simulation study. In: American Statistical Association Proceedings of the Biopharmaceutical Section, pp. 127–132 (1986)
Tallarida, R.J.: Drug Synergism and Dose-effect Data Analysis. Chapman and Hall/CRC, New York (2000)
Tallarida, R.J., Stone, D.J., Raffa, R.B.: Efficient designs for studying synergistic drug combinations. Life Sci. 61, 417–425 (1997)
Tan, M., Fang, H.B., Tian, G.L., Houghton, P.J.: Experimental design and sample size determination for drug combination studies based on uniform measures. Stat. Med. 22, 2091–2100 (2003)
Tan, M., Fang, H.B., Tian, G.L.: Dose and sample size determination for multi-drug combination studies. Stat. Biopharm. Res. 1, 301–316 (2009)
Tian, G.L., Fang, H.B., Tan, M., et al.: Uniform distributions in a class of convex polyhedrons with applications to drug combination studies. J. Multi. Anal. 100, 1854–1865 (2009)
Wan, W., Pei, X.Y., Grant, S.: Nonlinear response surface in the study of interaction analysis of three combination drugs. Biom. J. 59, 9–24 (2017)
Wiens, D.P.: Designs for approximately linear regression: two optimality properties of uniform designs. Stat. Probab. Lett. 12, 217–221 (1991)
Xavier, J.B., Sander, C.: Principle of system balance for drug interactions. New Engl. J. Med. 362, 1339–1340 (2010)
Yang, Y., Fang, H.B., Roy, A., Tan, M.: Adaptive oncology phase I trial design of drug combinations with drug-drug interaction modeling. Stat. Interface 11, 109–127 (2018)
Yin, G., Yuan, Y.: A latent contingency table approach to dose finding for combinations of two agents. Biometrics 65, 866–875 (2009)
Yin, G., Yuan, Y.: Bayesian dose finding in oncology for drug combinations by copula regression. J. R. Stat. Soc. Ser. C (Appl. Stat.) 58, 211–224 (2009)
Yuan, Y., Yin, G.: Sequential continual reassessment method for two-dimensional dose finding. Stat. Med. 27, 5664–5678 (2008)
Zhang, A.: Schur-convex discrimination of designs using power and exponential kernels. In: Fan, J., Li, G. (eds.) Contemporary Multivariate Analysis and Experimental Design, pp. 293–311. World Scientific Publisher, Singapore (2005)
Zhang, A., Fang, K.T., Li, R., Sudjianto, A.: Majorization framework for balanced lattice designs. Ann. Stat. 33, 2837–2853 (2005)
Acknowledgements
This research is partially supported by the National Cancer Institute (NCI) grant R01CA164717.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Tan, M.T., Fang, HB. (2020). Drug Combination Studies, Uniform Experimental Design and Extensions. In: Fan, J., Pan, J. (eds) Contemporary Experimental Design, Multivariate Analysis and Data Mining. Springer, Cham. https://doi.org/10.1007/978-3-030-46161-4_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-46161-4_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-46160-7
Online ISBN: 978-3-030-46161-4
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)